Bram Priem - Concepedia

Author

Bram Priem

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Bram Priem

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Eindhoven University of Technology Radboud University Medical Center University of Bonn Radboud University Nijmegen

About

Bram Priem is an author at Icahn School of Medicine at Mount Sinai specializing in engineering, biomedical engineering, and nanoparticles.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	596
2	Biomedical Engineering	4	4	596
3	Medicine	3	3	641
4	Biomolecular Engineering	3	3	563
5	Cell Biology	2	2	209

Bram Priem

Publications

883

Citations

H-Index

Page 1

	Year	Citations
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation Raphaël Duivenvoorden, Jun Tang, David P. Cormode, Nature Communications NanoparticlesInflammationEngineeringCardiovascular DiseaseAtherosclerotic Plaque Inflammation	2014	432
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition Bram Priem, Mandy M. T. van Leent, Abraham J. P. Teunissen, Cell Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2020	194
Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy Aneta J. Mieszawska, YongTae Kim, Anita Gianella, Bioconjugate Chemistry NanoparticlesPolymer–lipid NanoparticlesEngineeringDual Modality TherapyLipidic Corona	2013	116
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells David P. Schrijver, Rutger J. Röring, Jeroen Deckers, Nature Biomedical Engineering	2023	71
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors Stijn R. J. Hofstraat, Tom Anbergen, Robby Zwolsman, Nature Nanotechnology NanoparticlesNanomedicineCell-based Drug DeliveryEngineeringNature-inspired Platform Nanotechnology	2025	33
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy Annelies C. Wauters, Jari F. Scheerstra, Mandy M. T. van Leent, Nature Nanotechnology	2024	22
Targeted labeling of an early-stage tumor spheroid in a chorioallantoic membrane model with upconversion nanoparticles Kai Liu, Jasmin A. Holz, Yadan Ding, Nanoscale NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringTumor Biology	2014	15

Page 1